As of 2025-12-27, the Relative Valuation of Treace Medical Concepts Inc (TMCI) is (29.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.42 USD, the upside of Treace Medical Concepts Inc based on Relative Valuation is -1333.2%.
The range of the Relative Valuation is (27.87) - (28.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.4x - 46.2x | 41.4x |
| Forward P/E multiples | 31.4x - 36.8x | 34.5x |
| Fair Price | (27.87) - (28.91) | (29.84) |
| Upside | -1251.6% - -1294.5% | -1333.2% |
| Date | P/E |
| 2025-12-26 | -3.08 |
| 2025-12-24 | -3.10 |
| 2025-12-23 | -3.03 |
| 2025-12-22 | -3.15 |
| 2025-12-19 | -3.27 |
| 2025-12-18 | -3.17 |
| 2025-12-17 | -3.28 |
| 2025-12-16 | -3.43 |
| 2025-12-15 | -3.52 |
| 2025-12-12 | -3.56 |
| 2025-12-11 | -3.70 |
| 2025-12-10 | -3.64 |
| 2025-12-09 | -3.54 |
| 2025-12-08 | -3.32 |
| 2025-12-05 | -3.48 |
| 2025-12-04 | -3.48 |
| 2025-12-03 | -3.41 |
| 2025-12-02 | -3.43 |
| 2025-12-01 | -3.60 |
| 2025-11-28 | -3.79 |
| 2025-11-26 | -3.83 |
| 2025-11-25 | -3.93 |
| 2025-11-24 | -3.73 |
| 2025-11-21 | -3.64 |
| 2025-11-20 | -3.32 |
| 2025-11-19 | -3.46 |
| 2025-11-18 | -3.55 |
| 2025-11-17 | -3.68 |
| 2025-11-14 | -3.85 |
| 2025-11-13 | -3.99 |
| 2025-11-12 | -4.23 |
| 2025-11-11 | -4.27 |
| 2025-11-10 | -4.53 |
| 2025-11-07 | -5.68 |
| 2025-11-06 | -7.92 |
| 2025-11-05 | -7.95 |
| 2025-11-04 | -8.29 |
| 2025-11-03 | -8.38 |
| 2025-10-31 | -8.13 |
| 2025-10-30 | -8.07 |
| 2025-10-29 | -8.33 |
| 2025-10-28 | -8.70 |
| 2025-10-27 | -8.71 |
| 2025-10-24 | -8.74 |
| 2025-10-23 | -8.63 |
| 2025-10-22 | -8.72 |
| 2025-10-21 | -8.84 |
| 2025-10-20 | -8.65 |
| 2025-10-17 | -8.19 |
| 2025-10-16 | -8.11 |